Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
about
Flavonoids in Inflammatory Bowel Disease: A ReviewMedical Therapy of Active Ulcerative ColitisRole of cancer-associated fibroblasts in invasion and metastasis of gastric cancerFibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?Inflammatory pathways of importance for management of inflammatory bowel diseaseIntestinal epithelium in inflammatory bowel diseaseIn vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infectionA systems model of phosphorylation for inflammatory signaling eventsAddition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 MiceCurrent, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases.Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressionsEffects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients.New strategies for treatment of inflammatory bowel diseaseActivation of the JAK/STAT pathway in Behcet's disease.Reproductive Hormone and Transcriptomic Responses of Pituitary Tissue in Anestrus Gilts Induced by Nutrient Restriction.Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis.Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis.Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis.NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.Animal models of ulcerative colitis and their application in drug research.When combination therapy isn't working: emerging therapies for the management of inflammatory bowel diseaseMatrine induces the apoptosis of fibroblast-like synoviocytes derived from rats with collagen-induced arthritis by suppressing the activation of the JAK/STAT signaling pathway.Animal models of inflammatory bowel disease: a review.Natural products and their derivatives regulating the janus kinase/signal transducer and activator of transcription pathway.Immuno-genomic profiling of patients with inflammatory bowel disease: a systematic review of genetic and functional in vivo studies of implicated genes.Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease.Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future.Pathway-based approaches to the treatment of inflammatory bowel disease.Therapeutic innovations in inflammatory bowel diseases.Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.New treatment strategies for ulcerative colitis.JAK inhibition in inflammatory bowel disease.Will novel oral formulations change the management of inflammatory bowel disease?Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation.Tofacitinib for the treatment of ulcerative colitis.Emerging biologics in inflammatory bowel disease.IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
P2860
Q26748883-A01CDE71-2B64-45CF-B0AA-66385BD04417Q26777729-5B6F3007-A85A-49AE-9D9E-C80A85D3359DQ26781520-7F9FFD2C-7A2C-445B-8F85-4365B2D584BCQ26859968-4311EADC-189A-43D9-80C6-8E0EA67ACAB9Q27005445-5953E211-6664-4C86-BEDF-ABE573167131Q27022092-96B9ECD1-0EC2-4086-A9E9-A4C1E550CBE6Q27330386-E009C931-9E8C-498A-8753-4396F3A510F6Q28543980-21CF03F8-A6CF-4AEC-B6C7-C43D3E041F4EQ28551369-2E8FB7DF-69D0-423D-934A-AB66BE36F75AQ30902172-0499AC1D-0CB0-4C34-946F-E759F047BD26Q34443732-7E266244-6334-440C-8E1D-DB148A205876Q34467240-2DCEFF81-711E-410F-A7FE-D3139D71E437Q35069777-E4B8F22C-18BC-4E34-9B45-24A86661FD4EQ35647068-AAF5B948-5CEA-4E51-A91C-677A4CF121F8Q35845112-5E540064-5C39-4815-AA79-C9B57C4DBA68Q35860292-C120DE66-3BBE-4178-B29E-EADA380D7F6BQ35933419-EA73EC38-01C9-4FDB-BDD1-13476BA4B94AQ36010505-7434DD0B-C18B-4C83-B6AB-9DBD170D12B8Q36255322-721529AC-7180-4B38-AF7C-8FF4A95A54F9Q36341390-DEFD6B8B-8D05-4AFF-8237-34B15457231EQ36606775-8AF5F4D5-DD5F-4D4E-97B1-0D67ABA4F432Q37312835-4A339062-DE91-4FC6-A501-BD4D0C5AB111Q37578631-33ED09B1-5072-4AF8-BE2D-2486D4711C9DQ37711949-68486FB0-C39F-4642-8872-D0973F46383CQ38218335-B7735051-91F6-4990-96F7-0090003FFA1BQ38235327-6D13FC3C-AD43-4B63-955C-41CD05B20C0EQ38244620-B1E2FD9B-E5BA-428B-B5BD-0D3D6A71F8E6Q38253844-7BDAF331-78BD-4CAF-A4CD-121EB0DC432CQ38286034-51BBACBF-0CE4-4454-B74D-104FCC30D3BBQ38593257-7925D5BB-1697-43EB-8605-5601C94CC6ECQ38618178-3C5C402C-F803-4F80-93B0-E4730FA239AAQ38630854-0B3ED3F4-F383-4793-8D25-47002648DC0FQ38670811-5A6003F1-AB8E-44B1-85D6-7858D15DFF6AQ38761142-2663E073-E43E-41C5-9061-65AE0C0D2E86Q38769875-6DE4E9FC-F6CC-468F-AD79-EE84B7A22D54Q38773024-8FFD6BE5-E8B9-482C-B64E-F9945F40FF39Q38833865-460CEBF4-9421-4059-9992-5BB428CC364AQ39004625-86F78079-9A7A-4E8C-813B-898DC341B7BCQ39032463-C5782B8E-D30A-4A4B-A53A-95EB6167E39BQ39278136-904659FF-1799-4137-91DD-71EECDD02AA6
P2860
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
@en
type
label
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
@en
prefLabel
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
@en
P2093
P50
P921
P1476
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
@en
P2093
Jannie Pedersen
Mehmet Coskun
Mohammad Salem
P356
10.1016/J.PHRS.2013.06.007
P577
2013-07-02T00:00:00Z